<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03369613</url>
  </required_header>
  <id_info>
    <org_study_id>17-1322</org_study_id>
    <nct_id>NCT03369613</nct_id>
  </id_info>
  <brief_title>Transcranial Electrical Stimulation for Cervical Dystonia</brief_title>
  <official_title>Transcranial Electrical Stimulation (tES) for the Treatment of Cervical Dystonia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      There are two phases.&#xD;
&#xD;
      Phase I: A single visit which includes a screening, clinical scales, and a MRI scan with&#xD;
      simultaneous tES/sham tES in a randomized block design. Enrolls both Cervical Dystonia (CD)&#xD;
      patients and healthy controls.&#xD;
&#xD;
      Phase II: 5 consecutive days of 30-90 min visits to campus for tES or sham tES. Transcranial&#xD;
      magnetic stimulation (TMS) measures and clinical scales will also be included on Day 1 and&#xD;
      Day 5 visits. Enrolls only CD patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Phase I:&#xD;
&#xD;
      Enrolls both CD patients and healthy controls.&#xD;
&#xD;
      One approximately 3 hour visit which includes:&#xD;
&#xD;
        -  a screening &amp; neurological exam,&#xD;
&#xD;
        -  clinical scales &amp; questionnaires,&#xD;
&#xD;
        -  a (approx.) 60 min MRI scan with simultaneous tES/sham tES in a randomized block design&#xD;
           and EMG&#xD;
&#xD;
      Phase II:&#xD;
&#xD;
      Enrolls only CD patients.&#xD;
&#xD;
      Five consecutive days of study visits.&#xD;
&#xD;
      Day 1:&#xD;
&#xD;
        -  TMS screening,&#xD;
&#xD;
        -  repeated neurological assessment and clinical scales if &gt;1 month since MRI visit&#xD;
&#xD;
        -  30 min TMS session with concurrent EMG&#xD;
&#xD;
        -  20 min tES or sham tES session&#xD;
&#xD;
      Days 2-4:&#xD;
&#xD;
      - 20 min tES or sham tES session&#xD;
&#xD;
      Day 5:&#xD;
&#xD;
        -  20 min tES or sham tES session&#xD;
&#xD;
        -  30 min TMS session with concurrent EMG&#xD;
&#xD;
        -  repeated neurological assessment and clinical scales&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 27, 2017</start_date>
  <completion_date type="Anticipated">August 2022</completion_date>
  <primary_completion_date type="Anticipated">December 20, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Phase I: A change in brain functional connectivity in primary cervical dystonia</measure>
    <time_frame>Day 1</time_frame>
    <description>A change in mean functional connectivity between the pallidum and putamen during a resting state in CD patients during inhibitory tACS targeting the sensorimotor network.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Phase II: Improvement in Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) score</measure>
    <time_frame>Day 1, Day 5</time_frame>
    <description>A change in TWSTRS scores following five daily sessions of inhibitory tACS.</description>
  </primary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">55</enrollment>
  <condition>Primary Cervical Dystonia</condition>
  <arm_group>
    <arm_group_label>MRI - HC tDCS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Healthy controls in Phase 1 transcranial electrical stimulation set to direct current</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MRI - HC tACS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Healthy controls in Phase 1- transcranial electrical stimulation set to alternating current</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MRI - CD tCDS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cervical dystonia in Phase 1 transcranial electrical stimulation set to direct current</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MRI - CD tACS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cervical dystonia in Phase 1 transcranial electrical stimulation set to alternating current</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Phase II - Stim</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cervical dystonia in Phase 2 transcranial electrical stimulation setting is active</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Phase II - Sham</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Cervical dystonia in Phase 2 transcranial electrical stimulation setting is sham</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>transcranial electrical stimulation</intervention_name>
    <description>The device is a Neoprene headcap that holds an array of padded electrodes close to the scalp to stimulate the underlying brain.</description>
    <arm_group_label>MRI - CD tACS</arm_group_label>
    <arm_group_label>MRI - CD tCDS</arm_group_label>
    <arm_group_label>MRI - HC tACS</arm_group_label>
    <arm_group_label>MRI - HC tDCS</arm_group_label>
    <arm_group_label>Phase II - Sham</arm_group_label>
    <arm_group_label>Phase II - Stim</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Primary Cervical Dystonia&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  Right-handed&#xD;
&#xD;
          -  On a stable dose of all medications used to treat dystonia for the month previous to&#xD;
             enrollment&#xD;
&#xD;
          -  No botox injections in the 10 weeks previous to enrollment&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any contraindication to MRI scanning, tES, or TMS (e.g pregnancy, history of seizures,&#xD;
             significant systemic medical conditions, untreated psychiatric or neurological&#xD;
             conditions)&#xD;
&#xD;
          -  Evidence on neurological exam of any potentially confounding neurological disorder&#xD;
&#xD;
          -  Evidence of significant cognitive impairment&#xD;
&#xD;
          -  Patients with dystonia symptoms beginning prior to the age of 18 will be excluded&#xD;
&#xD;
          -  Patients with secondary dystonia resulting from medications or that are part of&#xD;
             another neurological disorder (e.g. Parkinson's disease) will be excluded&#xD;
&#xD;
          -  Medication that might predispose the subject to seizures&#xD;
&#xD;
        Healthy Controls&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
        - Right-handed&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any contraindication to MRI scanning, tES, or TMS (e.g pregnancy, history of seizures,&#xD;
             significant systemic medical conditions, untreated psychiatric or neurological&#xD;
             conditions)&#xD;
&#xD;
          -  Evidence on neurological exam of any potentially confounding neurological disorder&#xD;
&#xD;
          -  Evidence of significant cognitive impairment&#xD;
&#xD;
          -  Medication that might predispose the subject to seizures&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brian Berman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Colorado Denver</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>November 29, 2017</study_first_submitted>
  <study_first_submitted_qc>December 8, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 12, 2017</study_first_posted>
  <last_update_submitted>October 11, 2021</last_update_submitted>
  <last_update_submitted_qc>October 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dystonia</mesh_term>
    <mesh_term>Dystonic Disorders</mesh_term>
    <mesh_term>Torticollis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

